Cerenome (CNSY) Live Share Price, Invest From India

Cerenome Stock Performance

as on November 5, 2026 at 7:59 am IST

Day's Low
Day's High
$0.78
Day's Price Range
$1.28
$0.87
10.36%
Downside
47.11%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$0.87
100.00%
Downside
-100.00%
Upside

Cerenome share price movements today

Previous Close: $1.30
Open: $1.28
Volume: 1.5M
Market Cap: $12.9M
Day's Low - High: $0.78 - $1.28

Cerenome Historical Returns

1 Month Return: + 6.87 %
3 Month Return: -51.42 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Cerenome Stock Fundamentals & Key Indicators

Check Cerenome market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$12.9M

EPS (TTM)

-1033.42

Dividend Yield

0.00%

PE Ratio (TTM)

Industry PE ratio

-3.13

PEG Ratio

0.00

Return On Equity TTM

-394.17%

Cerenome vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cerenome with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Cerenome	NA	$12.9M	NA	NA	89.58%	0.00%
Moderna	Neutral	$88.5B	-36.16%	-27.78	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$141.7B	192.56%	32.27	86.04%	0.00%
Regeneron	Buy	$95.5B	47.41%	19.76	85.77%	0.40%

Indian Investors' Interest in Cerenome Stock

Search interest for Cerenome Stock has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 6, 2026 to November 5, 2026

Change:-42% versus previous 30 day period

Cerenome Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	1	1	1	1	1	1	1	1	1	0
Gross Profit	1	1	1	1	0	1	1	1	0	0
Operating Income	-3	-3	-3	-3	-3	-1	-4	-5	-7	-9
EBITDA	-3	0	-2	-3	-13	5	-4	-2	-6	-8
Interest Expense	0	3	0	0	3	-	-	3	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-3	-2	-2	-3	-17	5	-4	-5	-6	-9
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-3	-2	-2	-3	-17	5	-4	-5	-6	-9
Net Profit Margin	88.91%	84.21%	84.07%	83.57%	82.91%	93.81%	93.84%	93.27%	89.40%	63.26%

Cerenome Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Mar 2019	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	6	2	6	0	-	0	4	5	5
Gross Profit	5	1	6	-2	0	0	-4	4	4
Operating Income	-20	-8	-3	-9	-12	-19	-13	-14	-15
EBITDA	-18	-6	0	-8	-12	-18	-12	-8	-18
Interest Expense	2	1	1	1	0	0	0	3	3
Depreciation	2	2	0	0	0	0	0	0	0
Income Before Tax	-22	-8	-3	-8	-13	-20	-13	-12	-22
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-22	-12	-10	-8	-13	-20	-13	-12	-22
Net Profit Margin	79.44%	61.52%	100.00%	-791.09%	0.00%	-217.86%	-97.23%	85.37%	91.46%

Cerenome Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-3	-2	-2	-3	-17	5	-4	-5	-6	-9
Operating Cash Flow	-4	-1	-3	-1	-6	-5	-2	-6	-6	-7
Investing Cash Flow	0	-3	0	0	3	-4	1	-1	-8	5
Financing Cash Flow	0	6	-	-	12	2	12	2	9	1
Change in Cash	-5	2	-3	-1	9	-7	11	-4	-5	0

Cerenome Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Mar 2019	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-22	-12	-10	-8	-13	-20	-13	-12	-22
Operating Cash Flow	-18	-11	-5	-8	-10	-12	-12	-10	-20
Investing Cash Flow	-1	0	5	0	0	0	0	-4	0
Financing Cash Flow	16	7	12	0	20	13	3	6	30
Change in Cash	-2	-4	12	-9	10	0	-9	-8	8

Global Institutional Holdings in Cerenome

Check out the Institutions with significant holdings in Cerenome.

Funds	Holdings
Vanguard	4.02%
VANGUARD INDEX FUNDS	3.82%
BlackRock, Inc.	1.26%
Fidelity Concord Street Trust	0.88%
Marc Hedrick	0.80%

See all

Insights on Cerenome

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 194.6% return, outperforming this stock by 291.4%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 861.9% return, outperforming this stock by 951.7%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 5 quarters, 5.15M → -9.00M (in $), with an average decrease of 66.6% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, CNSY stock has moved down by -25.3%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 4 quarters, 1.39M → 411.0K (in $), with an average decrease of 29.0% per quarter

About Cerenome

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.

Organisation	Cerenome
Headquarters	6420 Levit Green Blvd, Houston, TX, 77021, US
Industry	Medical - Pharmaceuticals
CEO	Marc H. Hedrick

Key Management of Cerenome

Name	Title
Dr. Eric J. Daniels M.B.A., M.D.	Chief Development Officer
Ms. Desiree Smith	Corporate Controller
Mr. Russell W. Bradley	President & GM of CNSide Diagnostics, LLC
Dr. Marc H. Hedrick M.B.A., M.D.	President, CEO & Director
Mr. Andrew J. Sims CPA	VP & CFO
Mr. Russ Havranek M.B.A., M.S.	Executive Vice President of Commercial and Corporate Strategy

FAQs

What is Cerenome share price today?

Cerenome share price today is $0.87 as on November 5, 2026 at 2:29 am IST at the close of the market. Cerenome share today touched a day high of $1.28 and a low of $0.78.

What is the 52 week high and 52 week low for Cerenome share?

Cerenome share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Cerenome stock price today i.e. November 5, 2026 at 2:29 am IST is closed at $0.87,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Cerenome's market capitalisation today?

Cerenome market capitalisation is $0.00T as on November 5, 2026 at 2:29 am IST.

How to invest in Cerenome Stock (CNSY) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cerenome on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Cerenome Stock (CNSY) from India?

Indian investors can start investing in Cerenome (CNSY) shares with as little as ₹94.63999938964844 or $1 (as of November 5, 2026 at 2:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.40 in Cerenome stock (as per the Rupee-Dollar exchange rate as on November 5, 2026 at 2:43 am IST). Based on Cerenome share’s latest price of $0.87 as on November 5, 2026 at 2:29 am IST, you will get 11.4929 shares of Cerenome. Learn more about fractional shares .